Jörn Tongers, MD, discusses early combined mechanical circulatory support with an Impella heart pump and VA ECMO in patients with refractory cardiogenic shock.
Marvin Slepian, MD, compares the hemocompatibility of Impella 5.5 to Centrimag discussing hemolysis, platelet activation, microparticle generation, and vWF alteration.
Learn when and how to use echocardiography to visualize in real-time the relationship of the Impella 5.5 with SmartAssist to structures within the left ventricle.
Yoshiki Sawa, MD, PhD, discusses a large multicenter study in Japan demonstrating high survival rates in AMI cardiogenic shock patients receiving the Impella heart pump.
Mark Anderson, MD presents his surgical perspectives on increasing survival in cardiogenic shock through escalation strategies that increase unloading.
Three intensivists discuss managing Impella patients in the CCU, focusing on weaning off inotropes, repositioning Impella, invasive monitoring, and use of Impella and ECMO.
Three physicians from the Cleveland Clinic discuss strategies for selecting the Impella® heart pump and/or ECMO as well as patient management and venting strategies.